Atlas Trials

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions

Clinical trial NCT05552495 · COMPLETED

Trial details

NCT number
NCT05552495
Sponsor
Chong Kun Dang Pharmaceutical
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypertension and Dyslipidemia
Start date
2022-09-23
Primary completion
2022-11-27
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.